Vaccinia Virus Arrests and Shifts the Cell Cycle.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
19 02 2022
Historique:
received: 18 01 2022
revised: 11 02 2022
accepted: 16 02 2022
entrez: 26 2 2022
pubmed: 27 2 2022
medline: 15 3 2022
Statut: epublish

Résumé

Modulation of the host cell cycle is a common strategy used by viruses to create a pro-replicative environment. To facilitate viral genome replication, vaccinia virus (VACV) has been reported to alter cell cycle regulation and trigger the host cell DNA damage response. However, the cellular factors and viral effectors that mediate these changes remain unknown. Here, we set out to investigate the effect of VACV infection on cell proliferation and host cell cycle progression. Using a subset of VACV mutants, we characterise the stage of infection required for inhibition of cell proliferation and define the viral effectors required to dysregulate the host cell cycle. Consistent with previous studies, we show that VACV inhibits and subsequently shifts the host cell cycle. We demonstrate that these two phenomena are independent of one another, with viral early genes being responsible for cell cycle inhibition, and post-replicative viral gene(s) responsible for the cell cycle shift. Extending previous findings, we show that the viral kinase F10 is required to activate the DNA damage checkpoint and that the viral B1 kinase and/or B12 pseudokinase mediate degradation of checkpoint effectors p53 and p21 during infection. We conclude that VACV modulates host cell proliferation and host cell cycle progression through temporal expression of multiple VACV effector proteins. (209/200.).

Identifiants

pubmed: 35216024
pii: v14020431
doi: 10.3390/v14020431
pmc: PMC8874441
pii:
doi:

Substances chimiques

Tumor Suppressor Protein p53 0
Viral Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MC_UU_00012/7
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : R01 AI114653
Pays : United States
Organisme : NIAID NIH HHS
ID : R56 AI153099
Pays : United States

Références

Methods Mol Biol. 2005;296:113-53
pubmed: 15576929
J Virol. 2017 Jul 12;91(15):
pubmed: 28515294
J Cell Physiol. 1979 Aug;100(2):251-62
pubmed: 511944
J Virol. 2008 Sep;82(17):8687-94
pubmed: 18596103
Cold Spring Harb Perspect Biol. 2013 Sep 01;5(9):
pubmed: 24003211
Science. 1964 Nov 27;146(3648):1172-4
pubmed: 14203679
Front Cell Infect Microbiol. 2018 Nov 19;8:396
pubmed: 30510918
Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7653-7
pubmed: 8052637
Methods Mol Biol. 2018;1686:1-25
pubmed: 29030809
DNA Cell Biol. 1999 Nov;18(11):837-43
pubmed: 10595397
Cell Host Microbe. 2014 Jan 15;15(1):103-12
pubmed: 24439902
J Virol. 2008 Jun;82(12):5922-32
pubmed: 18417590
Cell Cycle. 2008 Aug;7(15):2434-40
pubmed: 18677105
PLoS Biol. 2006 Mar;4(3):e83
pubmed: 16509772
J Cell Sci. 2015 Dec 1;128(23):4255-62
pubmed: 26567218
Methods Mol Biol. 2014;1170:165-227
pubmed: 24906315
Cell. 2008 Feb 8;132(3):487-98
pubmed: 18267078
Adv Virus Res. 2006;66:31-124
pubmed: 16877059
Mol Biol Rep. 2016 Nov;43(11):1213-1220
pubmed: 27558094
PLoS Pathog. 2019 Feb 15;15(2):e1007608
pubmed: 30768651
Cell. 1992 Nov 13;71(4):587-97
pubmed: 1423616
Cancer Res. 1995 Nov 15;55(22):5187-90
pubmed: 7585571
Mol Cell Biol. 1999 Mar;19(3):1751-8
pubmed: 10022862
Nat Rev Mol Cell Biol. 2019 Apr;20(4):199-210
pubmed: 30824861
Cell Rep. 2017 May 2;19(5):1022-1032
pubmed: 28467896
Virology. 1960 May;11:296-9
pubmed: 14419785
Cancer Res. 1997 Feb 15;57(4):604-9
pubmed: 9044834
Genes Dev. 1999 Jun 15;13(12):1501-12
pubmed: 10385618
J Virol. 1995 Dec;69(12):7823-34
pubmed: 7494294
J Virol. 2003 Jun;77(11):6493-506
pubmed: 12743306
Cell Rep. 2013 Aug 15;4(3):464-76
pubmed: 23891003
Chromosoma. 1992;102(1 Suppl):S72-82
pubmed: 1291243
Methods Mol Biol. 2011;761:151-61
pubmed: 21755447
Cell Microbiol. 2008 Mar;10(3):583-92
pubmed: 17877750
Science. 1998 Nov 20;282(5393):1497-501
pubmed: 9822382
Mol Cell Biol. 2003 Dec;23(23):8846-61
pubmed: 14612423
DNA Repair (Amst). 2004 Aug-Sep;3(8-9):997-1007
pubmed: 15279786
J Virol. 1968 May;2(5):401-8
pubmed: 4301310
Mol Cell Biol. 1995 May;15(5):2612-24
pubmed: 7739542
Virology. 1990 Jan;174(1):60-9
pubmed: 2294648
Virology. 1983 Jul 30;128(2):429-43
pubmed: 6577746
J Virol. 2005 Feb;79(4):2171-90
pubmed: 15681420
Nat Microbiol. 2018 May;3(5):588-599
pubmed: 29632367
Science. 2008 Apr 25;320(5875):531-5
pubmed: 18436786
Nature. 1994 Jun 16;369(6481):574-8
pubmed: 7911228
Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8493-7
pubmed: 7667317
Cell Prolif. 2003 Jun;36(3):131-49
pubmed: 12814430
Virology. 2004 Oct 25;328(2):254-65
pubmed: 15464845
Oncogene. 2001 Apr 5;20(15):1803-15
pubmed: 11313928
Cell. 1991 Dec 20;67(6):1169-79
pubmed: 1836977
Nat Microbiol. 2019 Oct;4(10):1636-1644
pubmed: 31285583
Proc Natl Acad Sci U S A. 1980 Jul;77(7):3957-61
pubmed: 6933445
Exp Cell Res. 1998 May 25;241(1):260-4
pubmed: 9633535
Biochem Biophys Res Commun. 1997 Jul 9;236(1):118-25
pubmed: 9223437
Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):7797-802
pubmed: 10393901
Nature. 1997 May 15;387(6630):299-303
pubmed: 9153396
Proc Natl Acad Sci U S A. 2006 Jul 11;103(28):10660-5
pubmed: 16818887
Cell. 1993 Jun 18;73(6):1059-65
pubmed: 8513492
Cell Host Microbe. 2013 Oct 16;14(4):468-80
pubmed: 24139403
EMBO J. 2017 Mar 1;36(5):604-616
pubmed: 28122869
Nature. 1991 Nov 28;354(6351):314-7
pubmed: 1659666
J Virol. 2001 Apr;75(7):3185-96
pubmed: 11238845
Mol Cell Biol. 2004 Dec;24(23):10366-80
pubmed: 15542844
Cell. 1994 Nov 18;79(4):551-5
pubmed: 7954821
Virology. 1981 Aug;113(1):224-41
pubmed: 7269240
Virology. 1962 Oct;18:274-85
pubmed: 14033129
Mol Cell. 2010 Oct 22;40(2):179-204
pubmed: 20965415
J Virol. 2010 Sep;84(17):8422-32
pubmed: 20538855
Cancer Res. 1968 Aug;28(8):1559-65
pubmed: 4876978
Genes Dev. 2004 Nov 15;18(22):2699-711
pubmed: 15545627
Virology. 1959 May;8(1):134-7
pubmed: 13669333
Nature. 1997 May 15;387(6630):296-9
pubmed: 9153395
J Biophys Biochem Cytol. 1961 Aug;10:475-503
pubmed: 13719413
J Virol. 1998 Apr;72(4):2917-26
pubmed: 9525612
Mol Cell Proteomics. 2017 Dec;16(12):2079-2097
pubmed: 28972080

Auteurs

Caroline K Martin (CK)

MRC Laboratory for Molecular Cell Biology, University College London, London WC1E 6BT, UK.

Jerzy Samolej (J)

Institute of Microbiology and Infection, University of Birmingham, Birmingham B15 2TT, UK.

Annabel T Olson (AT)

School of Biological Sciences, University of Nebraska, Lincoln, NE 68583, USA.

Cosetta Bertoli (C)

MRC Laboratory for Molecular Cell Biology, University College London, London WC1E 6BT, UK.

Matthew S Wiebe (MS)

School of Veterinary and Biomedical Sciences, University of Nebraska, Lincoln, NE 68583, USA.

Robertus A M de Bruin (RAM)

MRC Laboratory for Molecular Cell Biology, University College London, London WC1E 6BT, UK.

Jason Mercer (J)

Institute of Microbiology and Infection, University of Birmingham, Birmingham B15 2TT, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH